CG Oncology GAAP EPS of -$0.64 beats by $0.20, revenue of $1.6M beats by $1.07M

Seeking Alpha · Harsh Shukla · 2026-11-06 13:42 UTC

CG Oncology Q3 earnings beat estimates on EPS and revenue.

Earnings News CG Oncology GAAP EPS of -$0.64 beats by $0.20, revenue of $1.6M beats by $1.07M Nov 06, 2026, 8:42 AM ETCG Oncology, Inc. (CGON) StockBy: Harsh Shukla, SA News Editor CG Oncology press release (CGON): Q3 GAAP EPS of -$0.64 beats by $0.20. Revenue of $1.6M (-4.2% Y/Y) beats by $1.07M. Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters Sign Up More on CG Oncology CG Oncology: A Second-Mover Advantage In Bladder-Sparing Therapy CG Oncology, Inc. (CGON) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript CG Oncology: Circling Back After Huge Rally Seeking Alpha’s Quant Rating on CG Oncology Historical earnings data for CG Oncology Recommended For You More Trending News See More » Related Stocks Symbol Last Price % Chg Compare More on CGON Trending Analysis Trending News

Read the full story at Seeking Alpha · All coverage of this story